Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 21, 2014; 20(3): 673-683
Published online Jan 21, 2014. doi: 10.3748/wjg.v20.i3.673
Published online Jan 21, 2014. doi: 10.3748/wjg.v20.i3.673
Ref. | Study design | Probiotic strain (product; dose; time) | Patients | Diagnosis | Eradication | Test for confirming eradication | Comments |
n (%); P value | (time after completion of therapy) | ||||||
Cruchet et al[63] | DB, R | Lactobacillus johnsonii (La1), living or heat-killed, 80 mL/die, (> 107 CFU/mL) (Chamyto, Nestlé) and L. helveticus (LH) for 4 wk; Lactobacilli paracasei ST11, living or heat-killed, (> 107 CFU/mL) and LH for 4 wk | 252 (aged 6-17 yr) asymptomatic children and adolescents: Living La1/LH, n = 511; Heat-killed La1/LH, n = 501; Living ST11/LH, n = 501; Heat-killed ST11/LH, n = 511; LH, n = 501 | 13C-UBT | A moderate but significant difference in 13C-UBT values was detected in children receiving live La1, whereas no differences were observed in the other groups | 13C-UBT (at the end of treatment) | |
Gotteland et al[65] | R, DB, PC | Lactobacillus johnsonii La1, living or heat-killed, 80 mL/die, (> 107 CFU/mL) for 3 wk (Chamyto, Nestlé) with or without cranberry juice (CB) (200 mL) | 271 (aged 6-16 yr) asymptomatic children and adolescents: CB/La1, n = 701; Placebo juice/La1, n = 671; CB/heat-killed La1, n = 651; Placebo juice/heat-killed La1 (control), n = 691 | 13C-UBT | 16 (22.9)1 11 (16.9)1 10 (14.9)1vs 1 (1.5)1; P < 0.01 | 13C-UBT (a second 13C-UBT at the end of treatment and a third 13C-UBT after 1 mo) | The third UBT was carried out in only 19 of the 38 children found to be H. Pylori-negative in the second UBT: 12, 2, and 5 subjects from the CB/La1, placebo juice/La1, and CB/heat-killed La1 groups, respectively. Only four children (21) remained negative, after 1 mo without treatment: two from the placebo juice/La1 group and two from the CB/La1 group |
Boonyaritichaikij et al[66] | SB, PC | Lactobacillus gasseri OLL2716 (LG21), pieces of cheese weighing 1.6-2.0 g, approximately 5 × 108 CFU/g for 1 yr | 88 (aged 3-7 yr) asymptomatic children and adolescents completed the eradication arm: LG21, n = 821; ordinary cheese, n = 61 while 222 completed the prevention arm: LG21, n = 1231; Ordinary cheese, n = 991 | HpSA | 24 (29.3)1vs 0. In the randomized prevention arm: 5 (4.1) vs 8 (8.1); P = 0.21 were HpSA positive at 12 mo | HpSA (1 yr) | A total of 440 asymptomatic children were screened by the HpSA test. Thereafter 132 H. Pylori positive and 308 H. Pylori negative children were recruited to eradication and randomized prevention arms, respectively. Eradication was defined as reversion by HpSA at 12 mo; prevention as persistently HpSA negative at 12 mo |
-
Citation: Pacifico L, Osborn JF, Bonci E, Romaggioli S, Baldini R, Chiesa C. Probiotics for the treatment of
Helicobacter pylori infection in children. World J Gastroenterol 2014; 20(3): 673-683 - URL: https://www.wjgnet.com/1007-9327/full/v20/i3/673.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i3.673